SU811750A1 - Bis-bicarbonates of aliphatic diols as monomers for preparing polyurethanes and process for producing the same - Google Patents

Bis-bicarbonates of aliphatic diols as monomers for preparing polyurethanes and process for producing the same Download PDF

Info

Publication number
SU811750A1
SU811750A1 SU792810010A SU2810010A SU811750A1 SU 811750 A1 SU811750 A1 SU 811750A1 SU 792810010 A SU792810010 A SU 792810010A SU 2810010 A SU2810010 A SU 2810010A SU 811750 A1 SU811750 A1 SU 811750A1
Authority
SU
USSR - Soviet Union
Prior art keywords
bis
monomers
aliphatic diols
producing
polyurethanes
Prior art date
Application number
SU792810010A
Other languages
Russian (ru)
Inventor
М.М. Заалишвили
Р.Д. Кацарава
Т.М. Картвелишвили
Original Assignee
Институт Физиологии Им.С.И.Бериташвили
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Институт Физиологии Им.С.И.Бериташвили filed Critical Институт Физиологии Им.С.И.Бериташвили
Priority to SU792810010A priority Critical patent/SU811750A1/en
Application granted granted Critical
Publication of SU811750A1 publication Critical patent/SU811750A1/en

Links

Description

Изобретение относитс  к синтезу новых химических Лединений - бискарбонатов общей формулы: х-о-с-о-к-о-с-сж. где В сНг-сН2 сн -СНг сН2-сн-, X-4O W2;- p --N02-, ci .ei Cl Gl и choco6 их получени . Активированные бис карбонаты алифатических диолов  вл ютс  высокореакционными бифункциональными соединени ми и могут быть использованы дл  получени  высокомолекул рных поли уретанов и поликарбонатов. Указанные соединени , их свойства и способ получени  в .литературе не описаны. . Известны Cl 3 бифункциональные соJeдйнeни  на основе алифатических дио1лов - бис-хлорформиаты диолов, используемые в качестве мономеров в услови х поликонденсации дл  синтеза поли уретанов и поликарбонатов. Использование бис-хлорформиатов в i качестве мономеров в поликонденсации pЯJ недостатков 2 3 « -бис-хлорформиаты токсичные веществ вызывание коррозию; -они легко гидролизуютс  и их хранение затруднено , при гидролизе выдел ютс  2 моль двуокиси углерода и 2 «ОЛЬ .хлористого водорода и необходимо учитывать опасность повышени  давани ; -бис-хлорформиаты практически не пригодны дл  синтеза полиуретанов поликонденсацией в растворе, они реагируют со многими органическими растворител ми, что затрудн ет подбор растворителей дл  проведени  поликонденсации; 8П7 5 «О 15 20 25 02 -бис-хлорфррмиаты бурно реагируют также с третичными аминами, используемыми в качестве акцептора хлористого водорода, что приводит к гибели функциональных групп и образованию низкомолекул рных полимеров - при синтезе бис-хлорформиатов различных диолов необходимо многократное использование фосгена, что осложн ет технологию процесса; -большинство бис-хлорформиатов алифатических диолов, - жидкости, что создает неудобства при работе с ними, они имеют высокие температуры кипеии  и очищаютс  лишь перегонкой в вакууме; -при синтезе р д бис-хлорформиатов, с короткой углеводородной цепью в качестве побочных продуктов образуютс  циклические карбонаты, что приводит к нарушению эквимолекул рности при проведении реакции поликонденсации. Целью изобретени   вл етс  синтез активированных бис-карбонатов алифатических диолов, которые могут быть использованы дл  получени  высокомолекул рных полиуретанов и поликарбонатов ., Поставленна  цель достигаетс  ноо структурой химических соединений бщей формулы: x-0-c-o-K-o-c-oXi гЗе R -cHrCH2-cH2-v -сНз СН2-СН2-СНСГ С1 Указанные соединени  получают заимодействием бис-хлорформиата алиатического диола с соединением, вы ранным ,из групп: нитрофенол, динитофенол , трихлорфенол, пентахлорфенрл, ли алифатический диол с хлорформиа3 том соединений из той же группы , в среде Органического растворител  в присутствии третичного амина в каО /-Л и ОглО/ °This invention relates to the synthesis of new chemical compounds - bis-carbonates of the general formula: x-o-c-c-c-s-comp. where b cnH cH2 cn cCHg cH 2 cn, X-4O W2; - p -N02-, ci .ei Cl Gl and choco6 are used to obtain them. Activated bis carbonates of aliphatic diols are highly reactive bifunctional compounds and can be used to produce high molecular weight polyurethanes and polycarbonates. These compounds, their properties and the method of their preparation are not described in the literature. . Cl 3 bifunctional compounds based on aliphatic dioles — diols bis chloroformates, used as monomers under polycondensation conditions for the synthesis of polyurethanes and polycarbonates are known. The use of bis-chloroformates as i monomers in the polycondensation of the pIJ deficiencies of 2 3 "-bis-chloroformates toxic substances causing corrosion; - they hydrolyze easily and their storage is difficult, during hydrolysis 2 moles of carbon dioxide and 2 "OLA of hydrogen chloride are released and the danger of pressure increase must be taken into account; - bis-chloroformates are practically unsuitable for the synthesis of polyurethanes by solution polycondensation, they react with many organic solvents, which makes it difficult to select solvents for carrying out polycondensation; 8P7 5 "О 15 20 25 02 -bis-chlorofrmimates also react violently with tertiary amines used as an acceptor of hydrogen chloride, which leads to the death of functional groups and the formation of low-molecular polymers - the synthesis of bis-chloroformates of various diols requires repeated use of phosgene, which complicates the process technology; Most of the bis-chloroformates of aliphatic diols, liquids, which cause inconvenience in working with them, they have high boiling points and are purified only by distillation in a vacuum; - during the synthesis of a series of bis-chloroformates, cyclic carbonates are formed as by-products with a short hydrocarbon chain, which leads to a violation of the equimolecularity during the polycondensation reaction. The aim of the invention is the synthesis of activated bis-carbonates of aliphatic diols, which can be used to obtain high molecular weight polyurethanes and polycarbonates. The goal is achieved by the structure of the chemical compounds of the formula: x-0-coKoc-oXi gze R -cHrCH2-cH2-v -sHz CH2-CH2-SNSH C1 These compounds are obtained by the interaction of an aliatic diol bis-chloroformate with a compound made from the following groups: nitrophenol, dinitophenol, trichlorophenol, pentachlorophenrel, or an aliphatic diol with chloroformate 3 of the compounds from t oh same group, in the environment of an Organic solvent in the presence of a tertiary amine in kaO / -L and Oglo / °

К 2,783 г (0,02 моль) п-нитрофенола при комнатной температуре прили- ю веют 30 мл сухого хлорбензола и 2,8мл {0,02 моль) триэтиламина. После пол1 эго растворени  п-нитрофенола раствор охлаж;с ают до -15 и медленно , аокапл м (риливакп раствор js 7,0t г (о,01 моль )бисхлорформиата li,3 пропандиола в 5 мл хлорбензола. После доьавлени  всего количества бисх Т-урформиата реакционную смесь перемешивают 15 мин,после чего охлаждение 2о30 ml of dry chlorobenzene and 2.8 ml {0.02 mol) of triethylamine are added to 2.783 g (0.02 mol) of p-nitrophenol at room temperature. After the complete dissolution of p-nitrophenol, the solution is cooled down to -15 and slowly, mixed (the solution js 7.0t g (o, 01 mol) of li bischloroformate, 3 propanediol in 5 ml of chlorobenzene. After the total amount of bis -urformate, the reaction mixture is stirred for 15 min, after which the cooling 2o

ОоOoh

51 « /51 "/

;О о-с-о-(сн21з-о-с-о- р. тч Щ Синтез осуществл ют в соответствии - методикой, приведенной в примере 1, с той разницей, что вместо п-нитроФенола берут 2,-динитрофенол.Продукт получаетс  в осадке в смеси с сол нокислым триэтиламином, его от фильтровывают, промывают спиртом и Синтез осуществл ют в соответствии с. методикой, приведенной в примере 1, с той разницей, что вместо п-нитрофенола берут 2,4,6-трихлорфенол. Продукт реакции - в растворе, поэтому реакционную смесь отфильтровывают от .выгнавшего сол нокислого триэтиламина, осадок промывают дважды небольшими О - oy-Q- -(() Cl Cl Синтез осуществл ют в соответствии с методикой, приведенной в примере 1, с той разницей, что вместо п-нитро- , фенола берут пентахлорФенол. Продукт выпадает из реакционного раствора вместе с сол нокислым триэтиламином, осадок отфильтровывают, промывают этиснимают и перемешивание продолжают при комнатной температуре в течение |1 ч. Продукт вместе с сол нокислым триэтиламином выпадает в осадок, который отфильтровывают и дл  удалени  сол нокислого триэтиламина промывают этиловым спиртом и, сушат. Получают . практически чистое белое кристаллическое вещество с т.пл. 131132°С. Выход после перекристаллизации мз толуола т.пл.132-133°С. Приме-р 2. 8П750 чес1йр катализатора и акцептора хлоригтого водорода при -15 - . . Пример 1. о 1 , сушат. Получают практически чистое, белое кристаллическоевещество с Т.пл. 87-88 е, выход 65%, после перекристаллизации из смеси толуола с :гексаном т.пл. . П р и м е р 3. ) з-о-с-о ( по 5 мл ) порци ми хлорбензола. Объединенный фильтр упаривают в вакууме. Получают белое кристаллическое вещество с т.пл. 107-110°С, выход 50, после перекристаллизации из гексана т.пл. 110-112 С. Пример t. С1 С1 -Q. СГ С1 ловым спиртом и сушат. Получают белое кристаллическое, практически чистое вещество с т.пл. , выход 75. После перекристаллизации из смеси толуола с гексаном т.пл. 17б-178 с. Примерз.; About o-c-o- (sn 213-o-c-o-r. Tch W. Synthesis is carried out in accordance with the procedure described in Example 1, with the difference that 2, -dinitrophenol is taken instead of p-nitro-phenol. Product is obtained in the sediment in a mixture with hydrochloric triethylamine, it is filtered, washed with alcohol, and the synthesis is carried out in accordance with the procedure described in example 1, with the difference that 2,4,6-trichlorophenol is taken instead of p-nitrophenol. reactions in solution, therefore, the reaction mixture is filtered from the expelled triethylamine hydrochloride, the precipitate is washed twice We use small O - oy-Q- - (() Cl Cl Synthesis is carried out in accordance with the procedure described in Example 1, with the difference that pentachlorophenol is taken instead of p-nitro and phenol. The product falls out of the reaction solution along with the salt triethylamine, acidic precipitate is filtered off, washed with ethinuid and stirring is continued at room temperature for 1 hour. The product together with triethylamine hydrochloride precipitates, which is filtered off and washed with ethyl alcohol to remove triethylamine and dried. Get it. almost pure white crystalline substance with so pl. 1,31132 ° C. The output after recrystallization mz toluene, mp 132-133 ° C. Example 2. 8P750 car1 catalyst and hydrogen chlorine acceptor at -15 -. . Example 1. about 1, dried. An almost pure, white crystalline substance is obtained with m.p. 87-88 e, yield 65%, after recrystallization from a mixture of toluene with: hexane so pl. . PRI me R 3.) Cr-o-o (5 ml) in portions of chlorobenzene. The combined filter is evaporated in vacuo. A white crystalline substance is obtained with a mp. 107-110 ° C, yield 50, after recrystallization from hexane so pl. 110-112 C. Example t. C1 C1 -Q. SG C1 lov alcohol and dried. A white, crystalline, practically pure substance is obtained. , exit 75. After recrystallization from a mixture of toluene with hexane so pl. 17b-178 s. Froze

ОСКз О OSKz Oh

Ю)-о-с-о- Шг сНг са-о-с-оYu) -o-s-o-Shg CNG sa-o-s-o

Синтез осуществл ют в cooTBetciBHM с методикой, приведенной в 1римере t, с той разницей, мто вместо бис-хлорформиата 1,3-прбпандиола используют бис-хлорфррмиат t,З-бутандиола. Продукт выпадает из реакционного раствора в виде осадка вместе с сол нокисг The synthesis is carried out in cooTBetciBHM with the procedure given in example t, with the difference that it is used instead of bis-chloroformate 1,3-prbpandiol using bis-chlorofrmiate t, 3-butanediol. The product precipitates from the reaction solution as a precipitate along with hydroxys

ЧО)-о-с-о-снгсН2--си-о-с оCHO) -o-s-o-sngsN2 - C-o-s o

Синтез осуществл ют в соответствии 20 с методикой приведенной в примере 1, . с той разницей, что BMeicto бисхлорформиата 1 13-пропандиола используют бис-хлорформиат 1,3-бутандиола, аThe synthesis is carried out in accordance with the procedure described in Example 1,. with the difference that BMeicto bischloroformate 1 13-propanediol use bis-chloroformate 1,3-butanediol, and

вместо п-нитрофенола - пеНтахлорфенол 5 Продукт реакции в растворе, поэтому реакционную смесь отфильтровывают от выпавшего сол нокислого триэтиламина.instead of p-nitrophenol, petachlorophenol 5 The reaction product is in solution, therefore, the reaction mixture is filtered from the precipitated hydrochloric triethylamine.

лым триэтиламииом, осадок отфильтровывают , промывают этиловым спиртом и сушат. Получают белое, кристаллическое вещество с т.пл. , выход 6k%t после перекристаллизации из толуЬ а т.пл. l47-lA8 t, Синтез 6.solid triethylamiomy, the precipitate is filtered off, washed with ethyl alcohol and dried. A white, crystalline substance is obtained. , yield 6k% t after recrystallization from tolu and so pl. l47-lA8 t, Synthesis 6.

СНз ОSNZ Oh

I UI u

осадок промывают дважды небольшими порци ми по 5 мл хлорбензола. Объединенный фильтрат упаривают в вакууме. Получают белое, кристаллическое вещество с т.пл. 137-139 0, выход 72%, после перекристаллизации из Н-бутанола т.пл. UO-Ua С.the precipitate is washed twice with small portions of 5 ml of chlorobenzene. The combined filtrate was evaporated in vacuo. A white, crystalline substance is obtained. 137-139 0, yield 72%, after recrystallization from N-butanol so pl. UO-Ua S.

П р и м е р 7.PRI me R 7.

|0| 0

IIII

0-с- о-( о- с-00-с-о- (о- с-0

к раствору 0,76 г {П,01 моль) 1,3-пропандиола и 1,б2 мл (0,02 моль) безводного пиридина в 30 мл сухого тетрагидрофурана при охлаждении до добавл ют г (0,02 моль) хлорформиата Г)-нитрофенола. После добавлени  всего количества хлорформиата охлаждение снимаюг и перемешиОto a solution of 0.76 g (P, 01 mol) of 1,3-propanediol and 1, B2 ml (0.02 mol) of anhydrous pyridine in 30 ml of dry tetrahydrofuran while cooling is added g (0.02 mol) of chloroformate G) -nitrophenol. After adding the total amount of chloroformate, cooling off and stirring

2лО/-о с-о(сН2)г сн-о-с-о- О)2лО / -о с-о (сН2) г sn-о-с-о-О)

Синтез осуществл ют в соответствии с методикой, приведенной в примере 7, с той разницей , что вместо 1,3-пропандиолаThe synthesis is carried out in accordance with the procedure given in example 7, with the difference that instead of 1,3-propanediol

вание продолжают при комнатной температуре в течение 2 ч. Выпавший осадок отфил ьтровывают, промывают этиловым спиртом и сушат. Т.пл. полученного вещества 130-132 С, выход 85, после перекристаллизации из толуола, т.пл. 132-133°С. Пример 8.Continue at room temperature for 2 hours. The precipitate formed is dried, washed with ethyl alcohol and dried. M.p. the obtained substance 130-132 C, yield 85, after recrystallization from toluene, so pl. 132-133 ° C. Example 8

СНч оSnch about

используют 1,3-бутандиол, т. пл. продукта , выход 82. После перекристаллизации из толуолаuse 1,3-butanediol, t. pl. product yield 82. After recrystallization from toluene

т.пл. , Основные А 71 132-133 1770 Толуол (перекристалА 65 88-90 1755 Толуол+гексан А 50 110-112 1765 Гексаи (перекристалА 75 176-178 1765 Толуол+гексаи А6. И7-1 8 1760- Толуол (перекристал1750 лизацией) . . (пЬемо) А72 1770 Н-бутанол (перё1780 криста лйзацией) (плв«ю) лизацией) (перекристаллизацией лизацией) (перекристаллизацией 7-в 750g характеристики активировэнмых бис-карбонатов общей формулы 50,16 3,23 6,61 (50.2«|)(3,)(6,9) «0,96 2,21 11,26 (1ц,13) (2,2) (11,29) 38,92 1,76 -Ю.Н ( 39,0) (1,,73) 3.78 ,0,76 -53,18 . (30,86) (0,91)-(53,7) 51,2« 3,68 6,58 (51 .««З) (3,81) (6,67) 31,92 V,02 -52,03 ( 32,0) (1,tS)152,6)m.p. , Basic A 71 132-133 1770 Toluene (recrystall A 65 88-90 1755 Toluene + hexane A 50 110-112 1765 Hexay (recrystall A 75 176-178 1765 Toluene + Hex A6. I7-1 8 1760- Toluene (by recrystallization 1750). . (pEmoo) A72 1770 N-butanol (before 1780 by crystallisation) (PLV) by lyse) (by recrystallization by crystallization) (by recrystallization of 7-in 750g characteristics of activated bis-carbonates of the general formula 50.16 3.23 6.61 (50.2 " |) (3,) (6.9) "0.96 2.21 11.26 (1st, 13) (2.2) (11.29) 38.92 1.76 - U.N (39.0 ) (1, 73) 3.78, 0.76 -53.18. (30.86) (0.91) - (53.7) 51.2 "3.68 6.58 (51." "H) (3.81) (6.67) 31.92 V, 02-52.03 (32.0) (1, tS) 152.6)

Claims (2)

БИС-КАРБОНАТЫ АЛИФАТИЧЕСКИХ ПН ЛОВ-МОНОМЕРЫ ДЛЯ ПОЛИУРЕТАНОВ И Поликарбонатов и способ их получения. (57 ) 1. Бис-карбонаты алифатических Диолов общей формулы гдеBIS-CARBONATES OF ALIPHATIC MON FISHING-MONOMERS FOR POLYURETHANES AND Polycarbonates and a method for their preparation. (57) 1. Bis-carbonates of aliphatic Diols of the general formula where -мономеры для полиуретанов и поликарбонатов.-monomers for polyurethanes and polycarbonates. 2. Способ получения соединений по п.1, заключающийся в том, что бисхлорформиат алифатического диола подвергают взаимодействию с соединением, выбранным из группы: нитрофенол, динитрофенол, трихпорфенол, пентахлорфенол, или алифатический диол с хлорформиатом соединений из той же группьц в среде органического растворителя в присутствии третичного амина в качестве катализатора и акцептора хлористого водорода при -15 ~ +25йС.2. The method for producing compounds according to claim 1, wherein the aliphatic diol bischloroformate is reacted with a compound selected from the group: nitrophenol, dinitrophenol, trichporphenol, pentachlorophenol, or an aliphatic diol with chloroformate of compounds from the same group in an organic solvent in presence of a tertiary amine as a catalyst and hydrogen chloride scavenger at -15 ~ 25 minutes C.
SU792810010A 1979-08-07 1979-08-07 Bis-bicarbonates of aliphatic diols as monomers for preparing polyurethanes and process for producing the same SU811750A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SU792810010A SU811750A1 (en) 1979-08-07 1979-08-07 Bis-bicarbonates of aliphatic diols as monomers for preparing polyurethanes and process for producing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SU792810010A SU811750A1 (en) 1979-08-07 1979-08-07 Bis-bicarbonates of aliphatic diols as monomers for preparing polyurethanes and process for producing the same

Publications (1)

Publication Number Publication Date
SU811750A1 true SU811750A1 (en) 1983-09-23

Family

ID=20846453

Family Applications (1)

Application Number Title Priority Date Filing Date
SU792810010A SU811750A1 (en) 1979-08-07 1979-08-07 Bis-bicarbonates of aliphatic diols as monomers for preparing polyurethanes and process for producing the same

Country Status (1)

Country Link
SU (1) SU811750A1 (en)

Cited By (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6503538B1 (en) 2000-08-30 2003-01-07 Cornell Research Foundation, Inc. Elastomeric functional biodegradable copolyester amides and copolyester urethanes
US7304122B2 (en) 2001-08-30 2007-12-04 Cornell Research Foundation, Inc. Elastomeric functional biodegradable copolyester amides and copolyester urethanes
US7648727B2 (en) 2004-08-26 2010-01-19 Advanced Cardiovascular Systems, Inc. Methods for manufacturing a coated stent-balloon assembly
US7648725B2 (en) 2002-12-12 2010-01-19 Advanced Cardiovascular Systems, Inc. Clamp mandrel fixture and a method of using the same to minimize coating defects
US7682669B1 (en) 2001-07-30 2010-03-23 Advanced Cardiovascular Systems, Inc. Methods for covalently immobilizing anti-thrombogenic material into a coating on a medical device
US7691401B2 (en) 2000-09-28 2010-04-06 Advanced Cardiovascular Systems, Inc. Poly(butylmethacrylate) and rapamycin coated stent
US7699889B2 (en) 2004-12-27 2010-04-20 Advanced Cardiovascular Systems, Inc. Poly(ester amide) block copolymers
US7713637B2 (en) 2006-03-03 2010-05-11 Advanced Cardiovascular Systems, Inc. Coating containing PEGylated hyaluronic acid and a PEGylated non-hyaluronic acid polymer
US7735449B1 (en) 2005-07-28 2010-06-15 Advanced Cardiovascular Systems, Inc. Stent fixture having rounded support structures and method for use thereof
US7749263B2 (en) 2004-10-29 2010-07-06 Abbott Cardiovascular Systems Inc. Poly(ester amide) filler blends for modulation of coating properties
US7758881B2 (en) 2004-06-30 2010-07-20 Advanced Cardiovascular Systems, Inc. Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device
US7766884B2 (en) 2004-08-31 2010-08-03 Advanced Cardiovascular Systems, Inc. Polymers of fluorinated monomers and hydrophilic monomers
US7772359B2 (en) 2003-12-19 2010-08-10 Advanced Cardiovascular Systems, Inc. Biobeneficial polyamide/polyethylene glycol polymers for use with drug eluting stents
US7775178B2 (en) 2006-05-26 2010-08-17 Advanced Cardiovascular Systems, Inc. Stent coating apparatus and method
US7776926B1 (en) 2002-12-11 2010-08-17 Advanced Cardiovascular Systems, Inc. Biocompatible coating for implantable medical devices
US7785647B2 (en) 2005-07-25 2010-08-31 Advanced Cardiovascular Systems, Inc. Methods of providing antioxidants to a drug containing product
US7785512B1 (en) 2003-07-31 2010-08-31 Advanced Cardiovascular Systems, Inc. Method and system of controlled temperature mixing and molding of polymers with active agents for implantable medical devices
US7795467B1 (en) 2005-04-26 2010-09-14 Advanced Cardiovascular Systems, Inc. Bioabsorbable, biobeneficial polyurethanes for use in medical devices
US7794743B2 (en) 2002-06-21 2010-09-14 Advanced Cardiovascular Systems, Inc. Polycationic peptide coatings and methods of making the same
US7803394B2 (en) 2002-06-21 2010-09-28 Advanced Cardiovascular Systems, Inc. Polycationic peptide hydrogel coatings for cardiovascular therapy
US7803406B2 (en) 2002-06-21 2010-09-28 Advanced Cardiovascular Systems, Inc. Polycationic peptide coatings and methods of coating implantable medical devices
US7807211B2 (en) 1999-09-03 2010-10-05 Advanced Cardiovascular Systems, Inc. Thermal treatment of an implantable medical device
US7807210B1 (en) 2000-10-31 2010-10-05 Advanced Cardiovascular Systems, Inc. Hemocompatible polymers on hydrophobic porous polymers
US7820732B2 (en) 2004-04-30 2010-10-26 Advanced Cardiovascular Systems, Inc. Methods for modulating thermal and mechanical properties of coatings on implantable devices
US7823533B2 (en) 2005-06-30 2010-11-02 Advanced Cardiovascular Systems, Inc. Stent fixture and method for reducing coating defects
US7892592B1 (en) 2004-11-30 2011-02-22 Advanced Cardiovascular Systems, Inc. Coating abluminal surfaces of stents and other implantable medical devices
US7976891B1 (en) 2005-12-16 2011-07-12 Advanced Cardiovascular Systems, Inc. Abluminal stent coating apparatus and method of using focused acoustic energy
US7985440B2 (en) 2001-06-27 2011-07-26 Advanced Cardiovascular Systems, Inc. Method of using a mandrel to coat a stent
US7985441B1 (en) 2006-05-04 2011-07-26 Yiwen Tang Purification of polymers for coating applications
US8007775B2 (en) 2004-12-30 2011-08-30 Advanced Cardiovascular Systems, Inc. Polymers containing poly(hydroxyalkanoates) and agents for use with medical articles and methods of fabricating the same
US8017140B2 (en) 2004-06-29 2011-09-13 Advanced Cardiovascular System, Inc. Drug-delivery stent formulations for restenosis and vulnerable plaque
US8021676B2 (en) 2005-07-08 2011-09-20 Advanced Cardiovascular Systems, Inc. Functionalized chemically inert polymers for coatings
US8029816B2 (en) 2006-06-09 2011-10-04 Abbott Cardiovascular Systems Inc. Medical device coated with a coating containing elastin pentapeptide VGVPG
US8052912B2 (en) 2003-12-01 2011-11-08 Advanced Cardiovascular Systems, Inc. Temperature controlled crimping
US8062350B2 (en) 2006-06-14 2011-11-22 Abbott Cardiovascular Systems Inc. RGD peptide attached to bioabsorbable stents
US8067025B2 (en) 2006-02-17 2011-11-29 Advanced Cardiovascular Systems, Inc. Nitric oxide generating medical devices
US8067023B2 (en) 2002-06-21 2011-11-29 Advanced Cardiovascular Systems, Inc. Implantable medical devices incorporating plasma polymerized film layers and charged amino acids
US8069814B2 (en) 2006-05-04 2011-12-06 Advanced Cardiovascular Systems, Inc. Stent support devices
US8109904B1 (en) 2007-06-25 2012-02-07 Abbott Cardiovascular Systems Inc. Drug delivery medical devices
US8110211B2 (en) 2004-09-22 2012-02-07 Advanced Cardiovascular Systems, Inc. Medicated coatings for implantable medical devices including polyacrylates
US8147769B1 (en) 2007-05-16 2012-04-03 Abbott Cardiovascular Systems Inc. Stent and delivery system with reduced chemical degradation
US8173199B2 (en) 2002-03-27 2012-05-08 Advanced Cardiovascular Systems, Inc. 40-O-(2-hydroxy)ethyl-rapamycin coated stent
US8192752B2 (en) 2003-11-21 2012-06-05 Advanced Cardiovascular Systems, Inc. Coatings for implantable devices including biologically erodable polyesters and methods for fabricating the same
US8293890B2 (en) 2004-04-30 2012-10-23 Advanced Cardiovascular Systems, Inc. Hyaluronic acid based copolymers
US8304012B2 (en) 2006-05-04 2012-11-06 Advanced Cardiovascular Systems, Inc. Method for drying a stent
US8303651B1 (en) 2001-09-07 2012-11-06 Advanced Cardiovascular Systems, Inc. Polymeric coating for reducing the rate of release of a therapeutic substance from a stent
US8357391B2 (en) 2004-07-30 2013-01-22 Advanced Cardiovascular Systems, Inc. Coatings for implantable devices comprising poly (hydroxy-alkanoates) and diacid linkages
US8435550B2 (en) 2002-12-16 2013-05-07 Abbot Cardiovascular Systems Inc. Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device
US8506617B1 (en) 2002-06-21 2013-08-13 Advanced Cardiovascular Systems, Inc. Micronized peptide coated stent
US8568764B2 (en) 2006-05-31 2013-10-29 Advanced Cardiovascular Systems, Inc. Methods of forming coating layers for medical devices utilizing flash vaporization
US8586069B2 (en) 2002-12-16 2013-11-19 Abbott Cardiovascular Systems Inc. Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders
US8597673B2 (en) 2006-12-13 2013-12-03 Advanced Cardiovascular Systems, Inc. Coating of fast absorption or dissolution
US8603634B2 (en) 2004-10-27 2013-12-10 Abbott Cardiovascular Systems Inc. End-capped poly(ester amide) copolymers
US8609123B2 (en) 2004-11-29 2013-12-17 Advanced Cardiovascular Systems, Inc. Derivatized poly(ester amide) as a biobeneficial coating
US8647655B2 (en) 2002-12-11 2014-02-11 Abbott Cardiovascular Systems Inc. Biocompatible polyacrylate compositions for medical applications
US8652504B2 (en) 2005-09-22 2014-02-18 Medivas, Llc Solid polymer delivery compositions and methods for use thereof
US8673334B2 (en) 2003-05-08 2014-03-18 Abbott Cardiovascular Systems Inc. Stent coatings comprising hydrophilic additives
US8685431B2 (en) 2004-03-16 2014-04-01 Advanced Cardiovascular Systems, Inc. Biologically absorbable coatings for implantable devices based on copolymers having ester bonds and methods for fabricating the same
US8703167B2 (en) 2006-06-05 2014-04-22 Advanced Cardiovascular Systems, Inc. Coatings for implantable medical devices for controlled release of a hydrophilic drug and a hydrophobic drug
US8703169B1 (en) 2006-08-15 2014-04-22 Abbott Cardiovascular Systems Inc. Implantable device having a coating comprising carrageenan and a biostable polymer
US8741378B1 (en) 2001-06-27 2014-06-03 Advanced Cardiovascular Systems, Inc. Methods of coating an implantable device
US8778014B1 (en) 2004-03-31 2014-07-15 Advanced Cardiovascular Systems, Inc. Coatings for preventing balloon damage to polymer coated stents
US8778375B2 (en) 2005-04-29 2014-07-15 Advanced Cardiovascular Systems, Inc. Amorphous poly(D,L-lactide) coating
US9028859B2 (en) 2006-07-07 2015-05-12 Advanced Cardiovascular Systems, Inc. Phase-separated block copolymer coatings for implantable medical devices
US9056155B1 (en) 2007-05-29 2015-06-16 Abbott Cardiovascular Systems Inc. Coatings having an elastic primer layer
US9102830B2 (en) 2005-09-22 2015-08-11 Medivas, Llc Bis-(α-amino)-diol-diester-containing poly (ester amide) and poly (ester urethane) compositions and methods of use
US9114198B2 (en) 2003-11-19 2015-08-25 Advanced Cardiovascular Systems, Inc. Biologically beneficial coatings for implantable devices containing fluorinated polymers and methods for fabricating the same
US9339592B2 (en) 2004-12-22 2016-05-17 Abbott Cardiovascular Systems Inc. Polymers of fluorinated monomers and hydrocarbon monomers
US9375445B2 (en) 2004-06-18 2016-06-28 Abbott Cardiovascular Systems Inc. Heparin prodrugs and drug delivery stents formed therefrom
US9517203B2 (en) 2000-08-30 2016-12-13 Mediv As, Llc Polymer particle delivery compositions and methods of use
US9561351B2 (en) 2006-05-31 2017-02-07 Advanced Cardiovascular Systems, Inc. Drug delivery spiral coil construct
US9561309B2 (en) 2004-05-27 2017-02-07 Advanced Cardiovascular Systems, Inc. Antifouling heparin coatings
US9580558B2 (en) 2004-07-30 2017-02-28 Abbott Cardiovascular Systems Inc. Polymers containing siloxane monomers
US10076591B2 (en) 2010-03-31 2018-09-18 Abbott Cardiovascular Systems Inc. Absorbable coating for implantable device

Cited By (93)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7807211B2 (en) 1999-09-03 2010-10-05 Advanced Cardiovascular Systems, Inc. Thermal treatment of an implantable medical device
US6503538B1 (en) 2000-08-30 2003-01-07 Cornell Research Foundation, Inc. Elastomeric functional biodegradable copolyester amides and copolyester urethanes
US7408018B2 (en) 2000-08-30 2008-08-05 Cornell Research Foundation, Inc. Elastomeric functional biodegradable copolyester amides and copolyester urethanes
US9517203B2 (en) 2000-08-30 2016-12-13 Mediv As, Llc Polymer particle delivery compositions and methods of use
US7691401B2 (en) 2000-09-28 2010-04-06 Advanced Cardiovascular Systems, Inc. Poly(butylmethacrylate) and rapamycin coated stent
US7807210B1 (en) 2000-10-31 2010-10-05 Advanced Cardiovascular Systems, Inc. Hemocompatible polymers on hydrophobic porous polymers
US8741378B1 (en) 2001-06-27 2014-06-03 Advanced Cardiovascular Systems, Inc. Methods of coating an implantable device
US10064982B2 (en) 2001-06-27 2018-09-04 Abbott Cardiovascular Systems Inc. PDLLA stent coating
US7985440B2 (en) 2001-06-27 2011-07-26 Advanced Cardiovascular Systems, Inc. Method of using a mandrel to coat a stent
US7682669B1 (en) 2001-07-30 2010-03-23 Advanced Cardiovascular Systems, Inc. Methods for covalently immobilizing anti-thrombogenic material into a coating on a medical device
US7304122B2 (en) 2001-08-30 2007-12-04 Cornell Research Foundation, Inc. Elastomeric functional biodegradable copolyester amides and copolyester urethanes
US8303651B1 (en) 2001-09-07 2012-11-06 Advanced Cardiovascular Systems, Inc. Polymeric coating for reducing the rate of release of a therapeutic substance from a stent
US8173199B2 (en) 2002-03-27 2012-05-08 Advanced Cardiovascular Systems, Inc. 40-O-(2-hydroxy)ethyl-rapamycin coated stent
US8961588B2 (en) 2002-03-27 2015-02-24 Advanced Cardiovascular Systems, Inc. Method of coating a stent with a release polymer for 40-O-(2-hydroxy)ethyl-rapamycin
US8506617B1 (en) 2002-06-21 2013-08-13 Advanced Cardiovascular Systems, Inc. Micronized peptide coated stent
US7875286B2 (en) 2002-06-21 2011-01-25 Advanced Cardiovascular Systems, Inc. Polycationic peptide coatings and methods of coating implantable medical devices
US7901703B2 (en) 2002-06-21 2011-03-08 Advanced Cardiovascular Systems, Inc. Polycationic peptides for cardiovascular therapy
US8067023B2 (en) 2002-06-21 2011-11-29 Advanced Cardiovascular Systems, Inc. Implantable medical devices incorporating plasma polymerized film layers and charged amino acids
US7803406B2 (en) 2002-06-21 2010-09-28 Advanced Cardiovascular Systems, Inc. Polycationic peptide coatings and methods of coating implantable medical devices
US9084671B2 (en) 2002-06-21 2015-07-21 Advanced Cardiovascular Systems, Inc. Methods of forming a micronized peptide coated stent
US7794743B2 (en) 2002-06-21 2010-09-14 Advanced Cardiovascular Systems, Inc. Polycationic peptide coatings and methods of making the same
US7803394B2 (en) 2002-06-21 2010-09-28 Advanced Cardiovascular Systems, Inc. Polycationic peptide hydrogel coatings for cardiovascular therapy
US8871236B2 (en) 2002-12-11 2014-10-28 Abbott Cardiovascular Systems Inc. Biocompatible polyacrylate compositions for medical applications
US8986726B2 (en) 2002-12-11 2015-03-24 Abbott Cardiovascular Systems Inc. Biocompatible polyacrylate compositions for medical applications
US7776926B1 (en) 2002-12-11 2010-08-17 Advanced Cardiovascular Systems, Inc. Biocompatible coating for implantable medical devices
US8647655B2 (en) 2002-12-11 2014-02-11 Abbott Cardiovascular Systems Inc. Biocompatible polyacrylate compositions for medical applications
US8871883B2 (en) 2002-12-11 2014-10-28 Abbott Cardiovascular Systems Inc. Biocompatible coating for implantable medical devices
US7648725B2 (en) 2002-12-12 2010-01-19 Advanced Cardiovascular Systems, Inc. Clamp mandrel fixture and a method of using the same to minimize coating defects
US8586069B2 (en) 2002-12-16 2013-11-19 Abbott Cardiovascular Systems Inc. Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders
US8435550B2 (en) 2002-12-16 2013-05-07 Abbot Cardiovascular Systems Inc. Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device
US8673334B2 (en) 2003-05-08 2014-03-18 Abbott Cardiovascular Systems Inc. Stent coatings comprising hydrophilic additives
US9175162B2 (en) 2003-05-08 2015-11-03 Advanced Cardiovascular Systems, Inc. Methods for forming stent coatings comprising hydrophilic additives
US7785512B1 (en) 2003-07-31 2010-08-31 Advanced Cardiovascular Systems, Inc. Method and system of controlled temperature mixing and molding of polymers with active agents for implantable medical devices
US9114198B2 (en) 2003-11-19 2015-08-25 Advanced Cardiovascular Systems, Inc. Biologically beneficial coatings for implantable devices containing fluorinated polymers and methods for fabricating the same
US8192752B2 (en) 2003-11-21 2012-06-05 Advanced Cardiovascular Systems, Inc. Coatings for implantable devices including biologically erodable polyesters and methods for fabricating the same
USRE45744E1 (en) 2003-12-01 2015-10-13 Abbott Cardiovascular Systems Inc. Temperature controlled crimping
US8052912B2 (en) 2003-12-01 2011-11-08 Advanced Cardiovascular Systems, Inc. Temperature controlled crimping
US7786249B2 (en) 2003-12-19 2010-08-31 Advanced Cardiovascular Systems, Inc. Biobeneficial polyamide/polyethylene glycol polymers for use with drug eluting stents
US7772359B2 (en) 2003-12-19 2010-08-10 Advanced Cardiovascular Systems, Inc. Biobeneficial polyamide/polyethylene glycol polymers for use with drug eluting stents
US8685431B2 (en) 2004-03-16 2014-04-01 Advanced Cardiovascular Systems, Inc. Biologically absorbable coatings for implantable devices based on copolymers having ester bonds and methods for fabricating the same
US8778014B1 (en) 2004-03-31 2014-07-15 Advanced Cardiovascular Systems, Inc. Coatings for preventing balloon damage to polymer coated stents
US9101697B2 (en) 2004-04-30 2015-08-11 Abbott Cardiovascular Systems Inc. Hyaluronic acid based copolymers
US7820732B2 (en) 2004-04-30 2010-10-26 Advanced Cardiovascular Systems, Inc. Methods for modulating thermal and mechanical properties of coatings on implantable devices
US8293890B2 (en) 2004-04-30 2012-10-23 Advanced Cardiovascular Systems, Inc. Hyaluronic acid based copolymers
US9561309B2 (en) 2004-05-27 2017-02-07 Advanced Cardiovascular Systems, Inc. Antifouling heparin coatings
US9375445B2 (en) 2004-06-18 2016-06-28 Abbott Cardiovascular Systems Inc. Heparin prodrugs and drug delivery stents formed therefrom
US8017140B2 (en) 2004-06-29 2011-09-13 Advanced Cardiovascular System, Inc. Drug-delivery stent formulations for restenosis and vulnerable plaque
US7758881B2 (en) 2004-06-30 2010-07-20 Advanced Cardiovascular Systems, Inc. Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device
US8758801B2 (en) 2004-07-30 2014-06-24 Abbott Cardiocascular Systems Inc. Coatings for implantable devices comprising poly(hydroxy-alkanoates) and diacid linkages
US8586075B2 (en) 2004-07-30 2013-11-19 Abbott Cardiovascular Systems Inc. Coatings for implantable devices comprising poly(hydroxy-alkanoates) and diacid linkages
US9580558B2 (en) 2004-07-30 2017-02-28 Abbott Cardiovascular Systems Inc. Polymers containing siloxane monomers
US8357391B2 (en) 2004-07-30 2013-01-22 Advanced Cardiovascular Systems, Inc. Coatings for implantable devices comprising poly (hydroxy-alkanoates) and diacid linkages
US7648727B2 (en) 2004-08-26 2010-01-19 Advanced Cardiovascular Systems, Inc. Methods for manufacturing a coated stent-balloon assembly
US7766884B2 (en) 2004-08-31 2010-08-03 Advanced Cardiovascular Systems, Inc. Polymers of fluorinated monomers and hydrophilic monomers
US8110211B2 (en) 2004-09-22 2012-02-07 Advanced Cardiovascular Systems, Inc. Medicated coatings for implantable medical devices including polyacrylates
US8603634B2 (en) 2004-10-27 2013-12-10 Abbott Cardiovascular Systems Inc. End-capped poly(ester amide) copolymers
US9067000B2 (en) 2004-10-27 2015-06-30 Abbott Cardiovascular Systems Inc. End-capped poly(ester amide) copolymers
US7749263B2 (en) 2004-10-29 2010-07-06 Abbott Cardiovascular Systems Inc. Poly(ester amide) filler blends for modulation of coating properties
US8609123B2 (en) 2004-11-29 2013-12-17 Advanced Cardiovascular Systems, Inc. Derivatized poly(ester amide) as a biobeneficial coating
US7892592B1 (en) 2004-11-30 2011-02-22 Advanced Cardiovascular Systems, Inc. Coating abluminal surfaces of stents and other implantable medical devices
US9339592B2 (en) 2004-12-22 2016-05-17 Abbott Cardiovascular Systems Inc. Polymers of fluorinated monomers and hydrocarbon monomers
US7699889B2 (en) 2004-12-27 2010-04-20 Advanced Cardiovascular Systems, Inc. Poly(ester amide) block copolymers
US8007775B2 (en) 2004-12-30 2011-08-30 Advanced Cardiovascular Systems, Inc. Polymers containing poly(hydroxyalkanoates) and agents for use with medical articles and methods of fabricating the same
US7795467B1 (en) 2005-04-26 2010-09-14 Advanced Cardiovascular Systems, Inc. Bioabsorbable, biobeneficial polyurethanes for use in medical devices
US8778375B2 (en) 2005-04-29 2014-07-15 Advanced Cardiovascular Systems, Inc. Amorphous poly(D,L-lactide) coating
US7823533B2 (en) 2005-06-30 2010-11-02 Advanced Cardiovascular Systems, Inc. Stent fixture and method for reducing coating defects
US8021676B2 (en) 2005-07-08 2011-09-20 Advanced Cardiovascular Systems, Inc. Functionalized chemically inert polymers for coatings
US7785647B2 (en) 2005-07-25 2010-08-31 Advanced Cardiovascular Systems, Inc. Methods of providing antioxidants to a drug containing product
US7735449B1 (en) 2005-07-28 2010-06-15 Advanced Cardiovascular Systems, Inc. Stent fixture having rounded support structures and method for use thereof
US9102830B2 (en) 2005-09-22 2015-08-11 Medivas, Llc Bis-(α-amino)-diol-diester-containing poly (ester amide) and poly (ester urethane) compositions and methods of use
US8652504B2 (en) 2005-09-22 2014-02-18 Medivas, Llc Solid polymer delivery compositions and methods for use thereof
US7976891B1 (en) 2005-12-16 2011-07-12 Advanced Cardiovascular Systems, Inc. Abluminal stent coating apparatus and method of using focused acoustic energy
US8067025B2 (en) 2006-02-17 2011-11-29 Advanced Cardiovascular Systems, Inc. Nitric oxide generating medical devices
US7713637B2 (en) 2006-03-03 2010-05-11 Advanced Cardiovascular Systems, Inc. Coating containing PEGylated hyaluronic acid and a PEGylated non-hyaluronic acid polymer
US7985441B1 (en) 2006-05-04 2011-07-26 Yiwen Tang Purification of polymers for coating applications
US8304012B2 (en) 2006-05-04 2012-11-06 Advanced Cardiovascular Systems, Inc. Method for drying a stent
US8069814B2 (en) 2006-05-04 2011-12-06 Advanced Cardiovascular Systems, Inc. Stent support devices
US7775178B2 (en) 2006-05-26 2010-08-17 Advanced Cardiovascular Systems, Inc. Stent coating apparatus and method
US9561351B2 (en) 2006-05-31 2017-02-07 Advanced Cardiovascular Systems, Inc. Drug delivery spiral coil construct
US8568764B2 (en) 2006-05-31 2013-10-29 Advanced Cardiovascular Systems, Inc. Methods of forming coating layers for medical devices utilizing flash vaporization
US8703167B2 (en) 2006-06-05 2014-04-22 Advanced Cardiovascular Systems, Inc. Coatings for implantable medical devices for controlled release of a hydrophilic drug and a hydrophobic drug
US8778376B2 (en) 2006-06-09 2014-07-15 Advanced Cardiovascular Systems, Inc. Copolymer comprising elastin pentapeptide block and hydrophilic block, and medical device and method of treating
US8029816B2 (en) 2006-06-09 2011-10-04 Abbott Cardiovascular Systems Inc. Medical device coated with a coating containing elastin pentapeptide VGVPG
US8118863B2 (en) 2006-06-14 2012-02-21 Abbott Cardiovascular Systems Inc. RGD peptide attached to bioabsorbable stents
US8062350B2 (en) 2006-06-14 2011-11-22 Abbott Cardiovascular Systems Inc. RGD peptide attached to bioabsorbable stents
US8114150B2 (en) 2006-06-14 2012-02-14 Advanced Cardiovascular Systems, Inc. RGD peptide attached to bioabsorbable stents
US9028859B2 (en) 2006-07-07 2015-05-12 Advanced Cardiovascular Systems, Inc. Phase-separated block copolymer coatings for implantable medical devices
US8703169B1 (en) 2006-08-15 2014-04-22 Abbott Cardiovascular Systems Inc. Implantable device having a coating comprising carrageenan and a biostable polymer
US8597673B2 (en) 2006-12-13 2013-12-03 Advanced Cardiovascular Systems, Inc. Coating of fast absorption or dissolution
US8147769B1 (en) 2007-05-16 2012-04-03 Abbott Cardiovascular Systems Inc. Stent and delivery system with reduced chemical degradation
US9056155B1 (en) 2007-05-29 2015-06-16 Abbott Cardiovascular Systems Inc. Coatings having an elastic primer layer
US8109904B1 (en) 2007-06-25 2012-02-07 Abbott Cardiovascular Systems Inc. Drug delivery medical devices
US10076591B2 (en) 2010-03-31 2018-09-18 Abbott Cardiovascular Systems Inc. Absorbable coating for implantable device

Similar Documents

Publication Publication Date Title
SU811750A1 (en) Bis-bicarbonates of aliphatic diols as monomers for preparing polyurethanes and process for producing the same
RU2674343C2 (en) 2-oxo-1,3-dioxolane-4-carboxamide building blocks, preparation and use thereof
JPS61501089A (en) Cyclic disulfonic acid ester compounds
CA1340884C (en) Radiation-sensitive, ethylenically unsaturated, copolymerizable compounds and their preparation
EP0511948A2 (en) Preparation of urethane and carbonate products
US3627813A (en) A process of preparing carbamates
JPH0745437B2 (en) Method for producing ester
JPS5934171B2 (en) Production method of bisphenol A polyalkyl carbonate ester
US3211774A (en) Process for preparing aromatic esters of chloroformic acid
Distaso et al. Group 3 metal (Sc, La) triflates as catalysts for the carbomethoxylation of aliphatic amines with dimethylcarbonate under mild conditions
EP0508430B1 (en) Process for the preparation of bisoxazolidines containing urethane groups
US4381404A (en) Process for the production of N,O-disubstituted urethanes and use thereof as starting materials for the production of organic isocyanates
ITMI951446A1 (en) PROCEDURE FOR THE PRODUCTION OF AROMATIC URETANS
US4137253A (en) Preparation of chloroformates having terminal acrylic or methacrylic groups
JPS62289554A (en) Novel hydroxyphenylurethanes, manufacture and use
US3769319A (en) N-ethyl-n-(1 - (m-trifluoromethylphenyl)-propyl-(2))-carbamic acid ethyl ester
US4851550A (en) Process for the preparation of cyclic aliphatic orthocarbonic esters new cyclic orthocarbonic esters
US3094538A (en) Carbonatopropyl dicarbamates
US3079302A (en) O[n-di-(chloroalkyl)carbamoyl] serine
JPS6226251A (en) Manufacture of bischloroformate composition
KR100219994B1 (en) Glyceraldehyde-3-pentanide and process for producing same
US3092656A (en) Method of manufacturing nu-substituted 2, 2-disubstituted-1, 3-propanediol dicarbamate
JP3851990B2 (en) Method for producing acryloylcarbamate
EP0556538A1 (en) Blocked tricarbamate compounds
US3472889A (en) Aminonitriles